MRNA Form 4: Stephen Hoge Converts 651 RSUs; 315 Shares Withheld for Taxes
Rhea-AI Filing Summary
Stephen Hoge, President of Moderna, Inc. (MRNA), reported transactions on Form 4 showing conversion and vesting of restricted stock units (RSUs) on 08/29/2025. A total of 651 RSUs converted into 651 shares of common stock and are reported as acquired; following the transactions he beneficially owns 1,453,827 shares directly and 156,049 shares indirectly (4,116 via Valhalla, LLC and 151,933 via a trust for his spouse and children). Additionally, 315 shares were withheld to satisfy tax withholding obligations related to vesting. The filing is signed by an attorney-in-fact on 09/02/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive RSU vesting and tax-withholding; no governance red flags disclosed.
The Form 4 documents standard vesting and conversion of restricted stock units for Moderna's President, with a small number of shares withheld for taxes. The report discloses both direct and indirect holdings, and includes a disclaimer regarding trust-owned shares held for family benefit. Transactions appear administrative rather than indicative of material changes in insider ownership control.
TL;DR: Minor insider share increase from RSU vesting; tax withholding reduced net share count.
The filing shows 651 RSUs converting into common stock and 315 shares withheld to satisfy tax obligations. The net effect is a modest increase in the reporting person's direct share count. The sizes reported are small relative to total holdings disclosed, suggesting limited market impact. All details are explicit and routine.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 651 | $0.00 | -- |
| Exercise | Common Stock | 651 | $0.00 | -- |
| Tax Withholding | Common Stock | 315 | $24.47 | $8K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Restricted stock units convert into common stock on a one-for-one basis. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
FAQ
What did Stephen Hoge report on the Form 4 for MRNA?
When did the reported transactions occur?